ZEAB Therapeutic LTD is currently carrying out drug development activities for the treatment of colorectal cancer with a patent application. The activities include ADME Investigation (in-silico, in-vitro and ex-vivo) in collaboration with reputable institutions (University of East London U.K., BIDMC – Harvard Medical School, U.S.A.)

ZEAB Therapeutic is also engaging the services of Cresset Discovery Services U.K. and Human Metabolomics Technology U.S.A